# Roflumilast

NDC: 70771-1674
Generic name: Roflumilast
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20221003

FDA application: ANDA208303

## Active ingredients

- ROFLUMILAST: 500 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1674"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1674
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e87287bd-eae3-46c3-9072-04800aeabf40